Topic: Neuro

Vesalio recently announced that it has oversubscribed its Class A financing round. Solas BioVentures led […]

ONWARD Medical has announced the first patient enrolment in the HemON study and first-in-human use […]

Flow Neuroscience, which claims to be the creator of Europe’s first medically approved brain stimulation […]

MicroTransponder recently announced the first commercial use of its Vivistim paired vagus nerve stimulation (VNS) […]

Vesalio has announced the completion of patient enrolment for the CLEAR US Food and Drug […]

CVRx (Nasdaq:CVRX) announced today that the FDA approved magnetic resonance (MR) conditional labeling for its Barostim […]

Synchron has announced the enrollment of the first patient in the US COMMAND clinical trial […]

Parkinson’s disease patients lack sufficient amounts of a neurotransmitter that plays a key role in […]

  Against the backdrop of remote learning technologies becoming increasingly important within medical training during […]

A team at the University of California San Diego has developed a smartphone app that […]

Testing giant Quest Diagnostics is diving into the market for blood tests that aid in […]

After a stroke time is of the essence, with a window of about an hour […]

ZAP Surgical Systems announced today that Baptist Health South Florida (Miami, USA) will acquire the […]

Engineers from the Massachusetts Institute of Technology (MIT) in Cambridge, USA have developed a telerobotic […]

Abbott today announced that it has launched an upgraded version of its NeuroSphere myPath digital […]

Axsome Therapeutics is bracing for another setback as the FDA is now expected to nix […]

Diagnosing Parkinson’s disease is challenging at all stages, due to variable symptoms, comorbidities, and mimicking […]

More than 5 million people in the United States are affected by limb loss or paralysis. […]

NeuraLace Medical has announced the expansion of its global patent portfolio with the issuance of […]

Boston Scientific (NYSE:BSX) today announced it received FDA approval for its Vercise Neural Navigator with StimView […]

Fujifilm Corporation has developed AI technology that can predict whether patients with mild cognitive impairment […]

Aidoc has received US Food and Drug Administration (FDA) 510(k) clearance for the triage and […]

Imeka announced today that it will collaborate with GE Healthcare (NYSE:GE) to expand magnetic resonance imaging (MRI) […]

Endovascular Engineering today announced the closing of a $15 million Series A1 financing co-led by Santé […]

Alejandro Spiotta (Medical University of South Carolina, Charleston, USA) outlines what he believes could be […]

Rapid Medical has announced US Food and Drug Administration (FDA) Breakthrough Device designation for its Comaneci embolisation assist […]

NovaSignal Corporation has announced the results of a multicentre, prospective, single-arm study indicating that the […]

Medtronic has received US Food and Drug Administration (FDA) approval of its Intellis rechargeable neurostimulator […]

Medtronic (NYSE:MDT) announced today that three-month data shows meaningful pain relief using its DTM spinal cord […]

Mainstay Medical has announced the publication of two-year patient outcomes data from its pivotal ReActiv8-B […]

Medtronic (NYSE: MDT) says a study shows its balloon kyphoplasty (BKP) and vertebroplasty (VP) technology […]

For the first time, biosensing earbuds leverage remote, highly-accurate and longitudinal EEG data to diagnose and improve management of neurological disorders

Nevro has announced three clinical data publications on treating painful diabetic neuropathy (PDN) with 10kHz […]

Magstim announced today that it received FDA 510(k) clearance for its Horizon 3.0 transcranial magnetic stimulation […]

Magnus Medical has announced that the US Food and Drug Administration (FDA) has granted the […]

NeoSpine is now offering spinal cord stimulation (SCS) procedures for the treatment of painful diabetic […]

The Plano, TX-based said it has signed an agreement to acquire Oscor for $220 million.

Theranica has announced the publication of a new, peer-reviewed article in Pain Reports detailing a […]

LivaNova is expected to get its first look at the RECOVER data for difficult-to-treat depression later this year.